Print

Print


Thought this might be of interest to the group


Sent from Samsung Mobile


-------- Original message --------
From: "Radford, Christine"
Date:29/08/2014 16:59 (GMT+00:00)
To: "Gray Yusuf (DERBY HOSPITALS NHS FOUNDATION TRUST)"
Subject: Ebola - information

Hello Yusuf

Please find below the information discussed earlier today regarding your concerns on handling positive or potentially positive Ebola sample material measured using Roche laboratory equipment.

Discussions have moved on considerably and we have been provided with information from our Roche Global Safety Health & Environment officer.

Please see the following statement:

 "Safety measures for the case that infected blood samples would be analysed on one of our pieces ......is a matter of very high concern to the health authorities in any country, and these authorities should be consulted for advice in these situations. These authorities will decide whether dedicated labs will be operated for such analyses, what will be the fate of an instrument that has accidentally been contaminated, what additional safety measures may be necessary and whether there should be restrictions regarding the import of samples of biological material from the outbreak area."

Any enquiries should be made to Public Health England (PHE), or the equivalent local public health authority.

Please see the links below for documentation provided by Public Health England regarding Ebola - Sent on behalf of Public Health England - Management of Hazard Group 4 viral haemorrhagic:

We would like to draw to your attention the publication of revised guidance on the 'Management of Hazard Group 4 viral haemorrhagic fevers and similar human infectious diseases of high consequence'  by the Advisory Committee on Dangerous Pathogens (ACDP) earlier this week. The guidance includes an updated algorithm (pg. 13), and appendix 7 covers laboratory testing aspects.
https://www.gov.uk/government/publications/viral-haemorrhagic-fever-algorithm-and-guidance-on-management-of-patients

The revised guidance complements the Ebola preparedness activities that are currently underway within Public Health England (PHE).
http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/Ebola/

PHE has drafted some 'Frequently Asked Questions' on laboratory testing and infection control and prevention. These are available at:
Summary Guidance for Acute Trust Staff: FAQ's on Ebola for Infection Control and Prevention staff

https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/346275/Summary_guidance_for_acute_trust_staff_Labs_15_08_2014.pdf


To conclude, at this time please contact your local public heath authority for advice/procedures and the equivalent documentation pertaining to the current Ebola situation.

If you have any further queries or concerns regarding this matter, please email myself or contact me through the Technical Services Helpline.

Kind regards,

Christine.

Christine Radford
Technical Product Specialist

Roche Diagnostics Limited
Charles Avenue
Burgess Hill
West Sussex
RH15 9RY
United Kingdom
Registration number 571546

Technical Hotline 0808 100 19 20
Tel:      +44 (0)1444 256786
Mobile: +44 (0)78944 19188
mailto: [log in to unmask]<mailto:[log in to unmask]>
www.roche-diagnostics.co.uk<http://www.roche-diagnostics.co.uk/>
www.roche.com<http://www.roche.com/>

Confidentiality Note: This message is intended only for the use of the named recipient(s) and may contain confidential and/or proprietary information.  If you are not the intended recipient, please contact the sender and delete the message.  Any unauthorised use of the information contained in this message is prohibited.





********************************************************************************************************************

This message may contain confidential information. If you are not the intended recipient please inform the
sender that you have received the message in error before deleting it.
Please do not disclose, copy or distribute information in this e-mail or take any action in reliance on its contents:
to do so is strictly prohibited and may be unlawful.

Thank you for your co-operation.

NHSmail is the secure email and directory service available for all NHS staff in England and Scotland
NHSmail is approved for exchanging patient data and other sensitive information with NHSmail and GSi recipients
NHSmail provides an email address for your career in the NHS and can be accessed anywhere

********************************************************************************************************************

------ACB discussion List Information--------
This is an open discussion list for the academic and clinical community working in clinical biochemistry.
Please note, archived messages are public and can be viewed via the internet. Views expressed are those of the individual and they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
Green Laboratories Work
http://www.laboratorymedicine.nhs.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/